Filters
Hikma improves performance in FTSE4Good Index
Press Release, Corporate
Hikma launches Dacarbazine for Injection, USP
Press Release, Product
Hikma successfully completes $500 million 5-year Eurobond issue
Press Release, Corporate
Transaction in Own Shares and Total Voting Rights and Capital
Press Release, Corporate
Hikma announces buy back of up to approximately £295 million of shares from Boehringer Ingelheim
Press Release, Corporate
Hikma and Sun Pharma enter into exclusive licensing agreement for ILUMYA™ for the Middle East and North Africa region
Press Release, Corporate
Hikma launches a generic version of Afinitor® Tablets, 2.5mg, 5mg, 7.5mg
Press Release, Product
Hikma launches Dicyclomine Hydrochloride Oral Solution
Press Release, Product
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
Press Release, Product
Hikma launches employee matching donation campaign to support local US food banks and pantries
Press Release, Corporate
Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain di...
Press Release, Corporate
Hikma launches Buprenorphine Hydrochloride Injection
Press Release, Corporate
Hikma launches Nicardipine Hydrochloride premixed injection in ready to use bags
Press Release, Corporate
Hikma appoints Douglas Hurt as Director
Press Release, Corporate